Cogent Biosciences, Inc.
COGT
Revenue
0.00
0.000.00%
-Assets
937.61M
▲511.67M▲120.13%
3 Months ChangeLiabilities
301.24M
▲177.77M▲143.98%
3 Months ChangeFree Cash Flow
-67.06M
▼-14.46M▼-27.49%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-17
Form 8-K
ID: 0001193125-26-053131
2025-12-08
Form 8-K
ID: 0001193125-25-311217
2025-11-18
Form 8-K
ID: 0001193125-25-286158
2025-11-13
Form 8-K
ID: 0001193125-25-278679
2025-11-10
Form 8-K
ID: 0001193125-25-273315
2025-11-07
Form 10-Q
ID: 0001193125-25-272334
2025-11-03
Form 8-K
ID: 0001193125-25-261797
2025-09-11
Form 8-K
ID: 0001193125-25-201353
2025-08-05
Form 10-Q
ID: 0000950170-25-102440
2025-08-05
Form 8-K
ID: 0000950170-25-102433